Remove tag rna-therapeutics
article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The synthesised oligonucleotides market segment is divided into primers, probes, DNA oligos, RNA oligos, and other synthesised oligos such as BNA & LNA oligos.

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). Physical characterisation.